Medical-risk Avoidance based on iPS Cells Team

Naonori Ueda (Ph.D.)

Title

Team Leader

Members

Team leader

Naonori Ueda
Research scientist

Ichigaku Takigawa
Technical scientist

Ayako Nagahashi
Technical staff I

Yuki Matsubayashi
Technical staff I

Takako Enami
Technical staff I

Ikuyo Inoue
Senior visiting scientist

Haruhisa Inoue
Visiting scientist

Masato Nakagawa
Visiting scientist

Takuya Yamamoto

Introduction

In cooperation with the iPS cell research institute (CiRA) of Kyoto university, by using AI and iPS cell technologies jointly, this team will research and develop technologies for predicting Altzheimer’s disease risk which is becoming social urgent matter. Moreover, we will conduct research develop technologies to ensure the safety of iPS cells themselves. The former results will improve the possibility of risk prediction of Altzhimer’s disease with solution, and the latter will enable the stock of high quality iPS cells for regenerative medicine.

RIKEN Website URL

https://www.riken.jp/en/research/labs/aip/goalorient_tech/med_risk_avoid_base_ips/index.html